1,412 companies

CompanyLast Price7D Return1Y ReturnMarket CapAnalysts TargetValuationGrowthDiv Yield

6IB

Innovent Biologics
HK$5.159.6%12.4%HK$76.0bHK$6.48PS9.2xE59.4%n/a

KY4

Kyowa Kirin
JP¥15.90-18.9%-1.2%JP¥1.4tJP¥20.78PE13.9xE3.0%2.3%

BUWA

Bio-Rad Laboratories
US$296.00-3.7%-11.8%US$9.2bUS$339.18PS3.6xE51.6%n/a

BUW

Bio-Rad Laboratories
US$278.000%-20.1%US$9.2bUS$318.55PS3.6xE51.6%n/a

9LB

Legend Biotech
US$43.800.9%-31.0%US$9.1bUS$73.77PS19.9xE63.7%n/a

A71

Ascendis Pharma
US$131.00-4.4%n/aUS$8.8bUS$175.68PS24.3xE67.9%n/a

22Z

Zealand Pharma
DKK 108.50-11.1%173.7%DKK 58.0bDKK 135.76PS157.5xE20.7%n/a

SMZ1

Sino Biopharmaceutical
HK$0.4110.6%24.1%HK$67.4bn/aPE28.4xE13.5%1.6%

08HH

Shanghai Fosun Pharmaceutical (Group)
CN¥1.5713.6%-25.9%CN¥60.2bCN¥1.70PE36.5xE29.7%1.1%

08HH

Shanghai Fosun Pharmaceutical (Group)
CN¥1.340%-37.8%CN¥60.2bCN¥1.45PE36.5xE29.7%1.1%

87S

Roivant Sciences
US$9.89-2.7%-17.6%US$8.6bUS$14.60PE1.8xE-55.6%n/a

CVG

CSPC Pharmaceutical Group
HK$0.6312.6%-6.4%HK$65.9bn/aPE10xE2.2%5.7%

CVGU

CSPC Pharmaceutical Group
HK$2.3813.3%-7.8%HK$65.9bHK$3.35PE10xE2.2%5.7%

1FW1

WuXi Biologics (Cayman)
HK$3.4628.1%-67.4%HK$65.6bHK$4.20PE22.5xE18.9%n/a

1FW2

WuXi Biologics (Cayman)
HK$1.7915.5%-67.3%HK$65.6bHK$2.17PE22.5xE18.9%n/a

IMU

ImmunoGen
US$28.746.8%615.5%US$8.4bUS$26.83PS29.1xE45.9%n/a

RGN

Repligen
US$130.451.1%-13.1%US$8.2bUS$173.26PS13.6xE91.8%n/a

23I

Intra-Cellular Therapies
US$66.00-3.6%29.9%US$7.7bUS$86.56PS13.7xE64.4%n/a

OFK0

Orion Oyj
€24.205.2%39.9%€6.9b€23.33PE29.6xE13.1%3.3%

OFK

Orion Oyj
€48.683.1%31.6%€6.9b€46.93PE29.6xE13.1%3.3%

4RY

Akeso
HK$7.704.1%78.2%HK$58.4bHK$7.52PS28.1xE54.5%n/a

EX9

Exelixis
US$24.02-2.3%19.1%US$7.4bUS$25.44PE21.2xE15.7%n/a

42Z

Revolution Medicines
US$39.00-4.9%45.5%US$7.3bUS$52.66PS9943.5xE12.8%n/a

RV7

Halozyme Therapeutics
US$50.84-4.2%38.0%US$7.2bUS$54.58PE21.4xE22.0%n/a
Page 7 of 59
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.